Thomas P. McGuire
About Thomas P. McGuire
Thomas P. McGuire is Senior Vice President and Chief Compliance Officer (CCO) of Columbia Seligman Premium Technology Growth Fund, Inc. (STK), serving in the role since 2012; he was born in 1972 and is based in Boston, MA . His primary occupation is Vice President – Asset Management Compliance at Ameriprise Financial, Inc. (the Fund’s manager’s parent), a position he has held since May 2010; he also serves as CCO for Columbia Acorn/Wanger Funds (since December 2015) and previously served as CCO of Ameriprise Certificate Company (September 2010 – September 2020) . Education and personal credentials are not disclosed in the Fund’s proxy, and no executive-specific performance metrics (TSR, revenue growth, EBITDA growth) are provided for the CCO role .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Columbia Seligman Premium Technology Growth Fund, Inc. (STK) | Senior Vice President & Chief Compliance Officer | 2012–Present | Leads regulatory compliance for the Fund and interfaces with Independent Directors via the Compliance Committee framework . |
| Ameriprise Financial, Inc. | Vice President – Asset Management Compliance | May 2010–Present | Oversees asset management compliance programs supporting Columbia Threadneedle affiliates . |
| Columbia Acorn/Wanger Funds | Chief Compliance Officer | Dec 2015–Present | CCO across affiliated fund complex; strengthens cross-complex compliance oversight . |
| Ameriprise Certificate Company | Chief Compliance Officer | Sept 2010–Sept 2020 | Led compliance for annuity/certificate business; tenure supports deep regulatory experience . |
External Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Ameriprise Financial, Inc. | Vice President – Asset Management Compliance | 2010–Present | Enterprise compliance leadership for the manager of STK; informs Fund compliance practices . |
| Columbia Acorn/Wanger Funds | Chief Compliance Officer | 2015–Present | Extends compliance oversight across related funds, enabling consistent policies and controls . |
| Ameriprise Certificate Company | Chief Compliance Officer | 2010–2020 | Prior leadership role in regulated products supporting broader compliance expertise . |
Fixed Compensation
- The Fund does not disclose base salary, target bonus, or actual bonus paid for officers; however, it explicitly notes that a portion of the Fund’s CCO compensation is paid by the funds within the Columbia Funds Complex (including STK); specific amounts are not disclosed .
- No disclosure of RSU/PSU grant values, option awards, vesting schedules, retention/sign-on bonuses, or perquisites for officers appears in the proxy; compensation detail is provided for Independent Directors only .
Performance Compensation
- No performance-based compensation metrics (e.g., revenue growth, EBITDA, TSR, ESG goals) are disclosed for the Fund’s officers; no payout formulas or weighting are provided .
- No clawback provisions, tax gross-ups, deferred compensation elections, pensions/SERP, or equity award modifications are disclosed for officers in the Fund’s proxy .
Equity Ownership & Alignment
- Individual officer beneficial ownership is not itemized; the proxy provides ranges for Directors and states group ownership for Directors and officers combined .
- No disclosure of pledged shares, hedging, stock ownership guidelines for officers, or compliance status appears in the proxy .
| Metric | FY 2023 | FY 2024 |
|---|---|---|
| Directors and officers as a group – Beneficial ownership of STK common stock | <1% | <1% |
Employment Terms
- Officers are elected annually by the Board and serve until successors are elected and qualify or earlier resignation; officers serve at the pleasure of the Board .
- The Compliance Committee provides a standing forum for the Fund’s CCO to meet regularly with Independent Directors on compliance matters; it met 5 times in 2023 and 4 times in 2024, highlighting ongoing engagement and oversight .
- Severance, change‑of‑control provisions (single/double trigger, multiples, accelerated vesting), non‑compete/non‑solicit, garden leave, and post‑termination consulting arrangements for officers are not disclosed in the Fund’s proxy .
Board Governance (CCO Interface)
- The Board’s Compliance Committee was expressly designed to provide a designated forum for the Fund’s CCO to report and discuss compliance matters with Independent Directors on a regular basis .
- The Board met 4 times in 2023 and 5 times in 2024, with committees meeting frequently across compliance, audit, contracts, and investment review, indicating structured governance and risk oversight processes that involve the CCO .
Investment Implications
- Compensation alignment signals cannot be assessed: the Fund does not disclose officer compensation detail (salary/bonus/equity), performance metrics, vesting schedules, severance, or change‑of‑control terms for the CCO; this limits pay‑for‑performance analysis and insider selling pressure assessments .
- Ownership alignment appears limited at the aggregate level (<1% for Directors and officers combined), and individual officer holdings, pledging, or hedging are not disclosed; this reduces the strength of “skin‑in‑the‑game” signals for trading models .
- Tenure and governance engagement: McGuire’s long tenure (CCO since 2012) and structured Compliance Committee interactions suggest continuity and ongoing compliance oversight, but without disclosed incentive structures or employment protections, retention risk and confidence signals for equity investors remain indeterminate .